Literature DB >> 32780450

The role of NOX4 in pulmonary diseases.

Zi-Ming Li1, Sheng-Ya Xu1, Yi-Zhuo Feng1, Yu-Rui Cheng1, Jian-Bing Xiong1, Yong Zhou1, Cha-Xiang Guan1.   

Abstract

Nicotinamide adenine dinucleotide phosphate oxidase 4 (NOX4) is a subtype of the NOX family, which is mainly expressed in the pulmonary vasculature and pulmonary endothelial cells in the respiratory system. NOX4 has unique characteristics, and is a constitutively active enzyme that primarily produces hydrogen peroxide. The signaling pathways associated with NOX4 are complicated. Negative and positive feedback play significant roles in regulating NOX4 expression. The role of NOX4 is controversial because NOX4 plays a protective or damaging role in different respiratory diseases. This review summarizes the structure, enzymatic properties, regulation, and signaling pathways of NOX4. This review then introduces the roles of NOX4 in different diseases in the respiratory system, such as acute respiratory distress syndrome, chronic obstructive pulmonary disease, and pulmonary fibrosis.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  NOX4; acute respiratory distress syndrome; chronic obstructive pulmonary disease; pulmonary fibrosis; signaling pathway

Year:  2020        PMID: 32780450     DOI: 10.1002/jcp.30005

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  7 in total

1.  MicroRNA-182-5p Attenuates Asthmatic Airway Inflammation by Targeting NOX4.

Authors:  Zhiguang Wang; Yilan Song; Jingzhi Jiang; Yihua Piao; Li Li; Qiaoyun Bai; Chang Xu; Hanye Liu; Liangchang Li; Hongmei Piao; Guanghai Yan
Journal:  Front Immunol       Date:  2022-05-31       Impact factor: 8.786

2.  NOX4 blockade suppresses titanium nanoparticle-induced bone destruction via activation of the Nrf2 signaling pathway.

Authors:  Wei Wang; Xiaolong Liang; Xin Liu; Jiaxiang Bai; Wei Zhang; Wenming Li; Tianhao Wang; Meng Li; Zerui Wu; Liang Chen; Huilin Yang; Ye Gu; Yunxia Tao; Jun Zhou; Huaiyu Wang; Dechun Geng
Journal:  J Nanobiotechnology       Date:  2022-05-23       Impact factor: 9.429

3.  NADPH-oxidase 4 gene over-expression in peripheral blood lymphocytes of the schizophrenia patients.

Authors:  Elizaveta S Ershova; Galina V Shmarina; Andrey V Martynov; Natalia V Zakharova; Roman V Veiko; Pavel E Umriukhin; George P Kostyuk; Sergey I Kutsev; Natalia N Veiko; Svetlana V Kostyuk
Journal:  PLoS One       Date:  2022-06-13       Impact factor: 3.752

Review 4.  Redox signaling at the crossroads of human health and disease.

Authors:  Jing Zuo; Zhe Zhang; Maochao Luo; Li Zhou; Edouard C Nice; Wei Zhang; Chuang Wang; Canhua Huang
Journal:  MedComm (2020)       Date:  2022-03-31

Review 5.  NADPH Oxidases in Pain Processing.

Authors:  Wiebke Kallenborn-Gerhardt; Katrin Schröder; Achim Schmidtko
Journal:  Antioxidants (Basel)       Date:  2022-06-14

Review 6.  Antioxidants as Therapeutic Agents in Acute Respiratory Distress Syndrome (ARDS) Treatment-From Mice to Men.

Authors:  Andreas von Knethen; Ulrike Heinicke; Volker Laux; Michael J Parnham; Andrea U Steinbicker; Kai Zacharowski
Journal:  Biomedicines       Date:  2022-01-04

Review 7.  Irreversibility of Pulmonary Fibrosis.

Authors:  Qing Yang Yu; Xiao Xiao Tang
Journal:  Aging Dis       Date:  2022-02-01       Impact factor: 6.745

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.